Performing Portfolio Acquired at a Discount Reflects Continued Progress in the Company's Asset-Backed Lending Strategy; Company Expects to Generate in Excess of $2 Million in Free Cash Flow Over the Coming Twelve Months Toronto, Ontario–(Newsfile…

Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations Toronto, Ontario–(Newsfile Corp. – May 21, 2026) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the…

Toronto, Ontario–(Newsfile Corp. – November 3, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to announce that it has entered into a share exchange agreement (the "Agreement") with McEwen…

Toronto, Ontario–(Newsfile Corp. – September 19, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") announced today that the closing of its previously announced non-brokered private placement offering of unsecured debentures (the…

Toronto, Ontario–(Newsfile Corp. – July 28, 2025) – Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to announce the launch of a non-brokered private placement offering of unsecured debentures (the "Debentures")…